Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Sep 24;79(1):4–6. doi: 10.1038/sj.bjc.6690002

Borderline ovarian tumours in Vaud, Switzerland: incidence, survival and second neoplasms

F Levi 1, C La Vecchia 2, L Randimbison 1, V-C Te 1
PMCID: PMC2362161  PMID: 10408684

Abstract

Between 1976 and 1996, 176 borderline ovarian tumours were registered in the Cancer Registry of the Swiss canton of Vaud, corresponding to an age-adjusted incidence (world standard) of 2.7 in 100 000. Incidence rose from 1.7 per 100 000 during 1976–81 to 2.7 per 100 000 during 1987–91, and then levelled off; 58% of cases were serous and 41% mucinous. Relative survival was 94% at 10 years; 18 second neoplasms were observed, compared with 10.3 expected, and there was a significant excess of invasive ovarian cancers (four observed, including three synchronous, compared with 0.4 expected). © 1999 Cancer Research Campaign

Keywords: ovarian tumours, low malignant potential tumours, borderline tumours, serous tumours, mucinous tumours, incidence, time trends, cancer registration, survival, second primary

Full Text

The Full Text of this article is available as a PDF (29.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Auranen A., Grénman S., Mäkinen J., Pukkala E., Sankila R., Salmi T. Borderline ovarian tumors in Finland: epidemiology and familial occurrence. Am J Epidemiol. 1996 Sep 15;144(6):548–553. doi: 10.1093/oxfordjournals.aje.a008964. [DOI] [PubMed] [Google Scholar]
  2. Barnhill D., Heller P., Brzozowski P., Advani H., Gallup D., Park R. Epithelial ovarian carcinoma of low malignant potential. Obstet Gynecol. 1985 Jan;65(1):53–59. [PubMed] [Google Scholar]
  3. Bjørge T., Engeland A., Hansen S., Tropé C. G. Prognosis of patients with ovarian cancer and borderline tumours diagnosed in Norway between 1954 and 1993. Int J Cancer. 1998 Mar 2;75(5):663–670. doi: 10.1002/(sici)1097-0215(19980302)75:5<663::aid-ijc1>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  4. Bjørge T., Engeland A., Hansen S., Tropé C. G. Trends in the incidence of ovarian cancer and borderline tumours in Norway, 1954-1993. Int J Cancer. 1997 May 29;71(5):780–786. doi: 10.1002/(sici)1097-0215(19970529)71:5<780::aid-ijc15>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  5. Harlow B. L., Weiss N. S., Lofton S. Epidemiology of borderline ovarian tumors. J Natl Cancer Inst. 1987 Jan;78(1):71–74. doi: 10.1093/jnci/78.1.71. [DOI] [PubMed] [Google Scholar]
  6. Hart W. R. Ovarian epithelial tumors of borderline malignancy (carcinomas of low malignant potential). Hum Pathol. 1977 Sep;8(5):541–549. doi: 10.1016/s0046-8177(77)80114-7. [DOI] [PubMed] [Google Scholar]
  7. Iscovich J., Shushan A., Schenker J. G., Paltiel O. The incidence of borderline ovarian tumors in Israel: a population-based study. Cancer. 1998 Jan 1;82(1):147–151. doi: 10.1002/(sici)1097-0142(19980101)82:1<147::aid-cncr18>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  8. Kaern J., Tropé C. G., Abeler V. M. A retrospective study of 370 borderline tumors of the ovary treated at the Norwegian Radium Hospital from 1970 to 1982. A review of clinicopathologic features and treatment modalities. Cancer. 1993 Mar 1;71(5):1810–1820. doi: 10.1002/1097-0142(19930301)71:5<1810::aid-cncr2820710516>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  9. Kennedy A. W., Hart W. R. Ovarian papillary serous tumors of low malignant potential (serous borderline tumors). A long-term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma. Cancer. 1996 Jul 15;78(2):278–286. doi: 10.1002/(SICI)1097-0142(19960715)78:2<278::AID-CNCR14>3.0.CO;2-T. [DOI] [PubMed] [Google Scholar]
  10. La Vecchia C., Negri E., Levi F., Decarli A., Boyle P. Cancer mortality in Europe: effects of age, cohort of birth and period of death. Eur J Cancer. 1998 Jan;34(1):118–141. doi: 10.1016/s0959-8049(97)00335-3. [DOI] [PubMed] [Google Scholar]
  11. La Vecchia C., Tavani A., Franceschi S., Parazzini F. Oral contraceptives and cancer. A review of the evidence. Drug Saf. 1996 Apr;14(4):260–272. doi: 10.2165/00002018-199614040-00006. [DOI] [PubMed] [Google Scholar]
  12. Leake J. F., Currie J. L., Rosenshein N. B., Woodruff J. D. Long-term follow-up of serous ovarian tumors of low malignant potential. Gynecol Oncol. 1992 Nov;47(2):150–158. doi: 10.1016/0090-8258(92)90099-5. [DOI] [PubMed] [Google Scholar]
  13. Levi F., Franceschi S., La Vecchia C., Ruzicka J., Gloor E., Randimbison L. Epidemiologic pathology of ovarian cancer from the Vaud Cancer Registry, Switzerland. Ann Oncol. 1993 Apr;4(4):289–294. doi: 10.1093/oxfordjournals.annonc.a058484. [DOI] [PubMed] [Google Scholar]
  14. Levi F., Lucchini F., La Vecchia C. Worldwide patterns of cancer mortality, 1985-89. Eur J Cancer Prev. 1994 Mar;3(2):109–143. doi: 10.1097/00008469-199403000-00004. [DOI] [PubMed] [Google Scholar]
  15. Levi F., Te V. C., Randimbison L., La Vecchia C. Trends in cancer incidence and mortality in Vaud, Switzerland, 1974-1993. Ann Oncol. 1996 Jul;7(5):497–504. doi: 10.1093/oxfordjournals.annonc.a010639. [DOI] [PubMed] [Google Scholar]
  16. Nakashima N., Nagasaka T., Oiwa N., Nara Y., Fukata S., Fukatsu T., Takeuchi J. Ovarian epithelial tumors of borderline malignancy in Japan. Gynecol Oncol. 1990 Jul;38(1):90–98. doi: 10.1016/0090-8258(90)90017-f. [DOI] [PubMed] [Google Scholar]
  17. Parazzini F., Franceschi S., La Vecchia C., Fasoli M. The epidemiology of ovarian cancer. Gynecol Oncol. 1991 Oct;43(1):9–23. doi: 10.1016/0090-8258(91)90003-n. [DOI] [PubMed] [Google Scholar]
  18. Parazzini F., Negri E., La Vecchia C., Moroni S., Polatti A., Chiaffarino F., Surace M., Ricci E. Treatment for fertility and risk of ovarian tumors of borderline malignancy. Gynecol Oncol. 1998 Mar;68(3):226–228. doi: 10.1006/gyno.1997.4928. [DOI] [PubMed] [Google Scholar]
  19. Parazzini F., Restelli C., La Vecchia C., Negri E., Chiari S., Maggi R., Mangioni C. Risk factors for epithelial ovarian tumours of borderline malignancy. Int J Epidemiol. 1991 Dec;20(4):871–877. doi: 10.1093/ije/20.4.871. [DOI] [PubMed] [Google Scholar]
  20. Rice L. W., Berkowitz R. S., Mark S. D., Yavner D. L., Lage J. M. Epithelial ovarian tumors of borderline malignancy. Gynecol Oncol. 1990 Nov;39(2):195–198. doi: 10.1016/0090-8258(90)90431-j. [DOI] [PubMed] [Google Scholar]
  21. Rossing M. A., Daling J. R., Weiss N. S., Moore D. E., Self S. G. Ovarian tumors in a cohort of infertile women. N Engl J Med. 1994 Sep 22;331(12):771–776. doi: 10.1056/NEJM199409223311204. [DOI] [PubMed] [Google Scholar]
  22. Scully R. E. Common epithelial tumors of borderline malignancy (carcinomas of low malignant potential). Bull Cancer. 1982;69(3):228–238. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES